Descurainia sophia is a plant widely distributed and used as folk medicine throughout the world. Different extracts of aerial parts and seeds of this plant have been shown to inhibit the growth of different cancer cell lines in vitro. In this study, cytotoxic activity of D. sophia seed volatile oil was evaluated. D. sophia seed powder was mixed with distilled water and left at 25 °C for 17 h (E1), 23 h (E2) and 28 h (E3) to autolyse. Then, the volatile fractions of E1, E2, and E3 were collected after steam distillation for 3 h. Cytotoxic effects of the volatile oils alone or in combination with doxorubicin (mixture of E1 or E2 at 50 µg/ml or E1 at 100 µg/ml with doxorubicin at 0.1, 1, 10 µM) against MCF-7 cell line were determined using MTT assay. Cytotoxic effect of E1 volatile oil was also determined on HeLa cell line. The results indicated that 1-buten-4-isothiocyanate was the major isothiocyanate found in the volatile oils. The results of cytotoxic evaluations showed that volatile constituents were more toxic on MCF-7 cells with IC 50 < 100 µg/ml than HeLa cells with IC 50 > 100 µg/ml. No significant differences were observed between cytotoxic activities of E1, E2 and E3 on MCF-7 cell line. Concomitant use of E1 and E2 (50 µg/ml) with doxurubicin (1 µM) significantly reduced the viability of MCF-7 cells compared to the negative control, doxorubicin alone, or each volatile fraction. The same result was obtained on HeLa cells, when E1 (100 µg/ml) was concurrently used with doxorubicin (1 µM).
INTRODUCTION
Descurainia sophia (L.) Weeb ex Prantl (Flixweed) belonging to the family Brassicaceae (Cruciferae) is a plant which is widely distributed throughout Europe, Asia and the Middle East (1, 2) . The extract of aerial parts of this plant is used in folk medicines for the treatment of throat diseases, measles and smallpox. Its tincture is used as diuretic, antihelmintic and hemostatic for internal hemorrhages (3) .
Seeds of Flixweed have been traditionally used to relieve cough, prevent asthma, reduce edema, promote urination and also for their cardiotonic effect (4) . Seeds have also been used in the Iranian traditional medicine for diarrhea (in boiled form) and constipation (in cold water), especially for the prevention of water loss and constipation among Iranian Hajj pilgrims (5) .
A new sinapoyl glycoside and a cytotoxic cardenolide glycoside from ethanolic extract of the seeds of D. sophia (6) have been reported. Biological screening of alcoholic extract of the aerial parts of D. sophia has shown analgesic, antipyretic and antiinflammatory effects (7) . Inhibitory effect of flixweed ethanolic extract on Streptomyces pyogenes has also been demonstrated (8) .
Analyses of the volatile constituents of aerial parts of D. sophia by gas chromatography (GC) and gas chromatography/mass spectrophotometry (GC/MS) indicated that cis-E. Khodarahmi et al. / RPS 2015; 10(2) : 169-176 170 β-ocimene, menthol and neoisomenthyl acetate are the predominant fractions of the volatile oil (4) . The seeds have also been shown to inhibit the growth of different cancer cell lines in vitro. For instance, n-butanol extract of the seeds significantly reduced the viability of NCI-H460, SF268 and SGC-7901 cell lines (4, 9, 10) .
Khan and coworkers demonstrated that a flavonol glycoside, artabotryside A, isolated from the seeds of D. sophia inhibited the growth of U87 glioblastoma cells through G2/M phase arrest and induction of caspase-3-dependent apoptosis (2). Kim and collegues indicated that the ethanol extract of the seeds of D. sophia induces dose-dependent responses in A549 human non-small cell lung carcinoma cells (11) .
Descurainolide A and B (new lactones), descurainin, strophanthidin and isorhamnetin-3-O-b-D-glucopyranoside were isolated from the ethanolic extract of the seeds of D. sophia, some of which have shown cytotoxicity on human stomach adenocarcinoma cell line (BGC-823 ) and human breast carcinoma cell line (MDA-MB-435) (12) .
The hydrolyzed products of glucosinolates, namely isothiocyanates, have been shown to possess various biological activities including anti oxidative, antibacterial, anticancer and chemoprotective properties. There is a reliable correlation between dietary intake of plants containing isothiocyanates and the decrease in cancer risks (13) .
Isothiocyanates may exert their cancer protection through various mechanisms including detoxification leading to decreased activation of pro-carcinogens and increased excretion of carcinogens. Detoxification enzymes are also upregulated by dietary crucifer. Furthermore, isothiocyanates may slow proliferation or increase apoptosis of cancer cells resulting in a retardation of tumor growth inhibiting CYP-dependent activation of pre-carcinogens (14) .
In the present study, the cytotoxic activity of the Flixweed seed volatile oils collected after autolysis of the powder for various times were studied on the MCF-7 and HeLa cell lines.
MATERIALS AND METHODS

Materials
Seeds of D. sophia were purchased from a reliable apothecary in the city of Isfahan. 
Autolysis and collection of the volatile constituents
Seed powder of D. sophia were mixed with distilled water and left for autolysis at 25 °C for 17 h (E1), 23 h (E2) and 28 h (E3) in appropriate containers. Autolysis is a hydrolytic breakdown of glucosinolates to volatile isothiocyanates through removing the glucose moiety from glucosinolates. Then volatile constituents (E1, E2 and E3) were collected by 3 h distillation using a semiindustrial distillation apparatus and kept in a refrigerator before the use (13) . The flavored water (FW) was also separated, freeze dried, and kept for subsequent cytotoxic studies.
In vitro cytotoxicity assay
Cytotoxic effects of the volatile oils alone (E1, E2, E3 at concentrations 25-250 µg/ml), FW (50-250 µg/ml)), or in combination with doxorubicin (mixture of E1 or E2 at 50 µg/ml or E1 at 100 µg/ml with doxorubicin at 0.1, 1, 10 µM) were determined against MCF-7 cell line using MTT assay. Cytotoxic effect of E1 volatile oil was also determined on HeLa cell line. In MTT assay, mitochondrial succinic dehydrogenase enzyme of viable cells would metabolically reduce the yellow soluble MTT salt into a purple insoluble formazan product. The purple solid could be dissolved in DMSO and measured spectrophotometrically at 540 nm using ELISA plate reader (15) .
MCF-7 and HeLa cells were grown in RPMI 1640 medium completed with 10% FBS and 1% penicillin/streptomycin. Cell lines were maintained in a humidified atmosphere of 5% CO2 and 95% air at 37 °C (15) . After 2-3 subcultures, 180 µl of cell suspension containing 2.5 × 10 4 and/or 5 × 10 4 cells per ml was seeded in 96 well microplates and incubated for 24 h (37 °C, air humidified 5% CO2). The stock solutions of E1, E2, E3, and freeze dried-FW were prepared by dissolving 10 mg of the corresponding volatile oils in 1 ml solvent composed of 60% deionized water and 40% DMSO.
These solutions were then appropriately diluted and 20 µl of each dilution was added to 96-wells microplate containing cell suspensions to reach 25, 50, 100, 120, 150, 180, 200 and 250 µg/ml final concentrations in the wells. Mixtures of E1 and E2 at concentration 50 µg/ml and doxorubicin solution at 0.1, 1, 10 µM were prepared for evaluation of synergic effects on MCF-7 cell line. Similar mixtures of E1 (100 µg/ml) and doxorubicin at 0.1, 1, 10 µM were also prepared to be evaluated on HeLa cells.
Doxorubicin was used as a positive control at 100 µM final concentration in the wells. The first column of the plate containing 180 µl of the cell suspension and 20 µl RPMI medium was regarded as negative control. The blank wells were consisted of 200 µl of the completed RPMI 1640 medium. After addition of each sample, the plates were further incubated for 48 h under the same condition.
To evaluate cell survival, each well was then incubated with 20 µl of MTT solution (5 mg/ml in phosphate buffer solution) for 3 h. Afterwards, the media in each well was gently replaced with 150 µl DMSO and pipetted to dissolve the formazan crystals. The absorbance of each well was measured at 540 nm using an ELISA plate reader (Awareness Stat Fax 2100, USA) (16) . Each experiment was carried out in triplicate and repeated in three different days. In the negative control, percent cell survival was assumed as 100%. The percentage of cell viability was calculated using the following formulation:
% Cell Survival = (Mean Abs. of the test compoundMean Abs. of the blank) / (Mean Abs. of the negative control -Mean Abs. of the blank) × 100
(1)
Statistical analysis
The results are the mean of three triplicate experiments. Analysis of variance (ANOVA) followed by LSD test using SPSS 10.0 program was used to determine the differences among various groups. The significance level was set at P<0.05.
RESULTS
The volatile constituents
The results of cytotoxic evaluation of E1, E2, E3 (25-250 µg/ml) and FW (50-250 µg/ml) on MCF-7 cells are depicted in Fig. 1 . As shown in Fig. 1, E1 , E2, and E3 showed cytotoxic effects at concentrations ≥100 µg/ml on MCF-7 cells as compared to control group (P<0.05).
Cell survival was diminished to less than 10% at concentrations of 150-250 µg/ml which is comparable to the cytotxic effect of the positive control, doxorubicin (100 µM). FW was cytotoxic to the MCF-7 cells at all the concentrations examined. The highest cytotoxic effect of FW was observed at 180 µg/ml which is also comparable to the cytotoxic effect of the positive control, doxorubicin.
The effect of concomitant use of E1 (50 µg/ml) with doxorubicin at various concentrations (0.1, 1, 10 µM) on MCF-7 cells (Fig. 2) indicates that the viability of MCF-7 cells was significantly reduced compared to E1 or doxorubicin alone, only when doxorubicin was used at 1 µM concentration (P<0.05), i.e. E1 (50 µg/ml) was able to induce additional 15% cell death while used with 1 µM doxorubicin. No significant synergetic effect was observed with other doxorubicin concentrations. 4 cell/ml) following exposure to the concentrations between 25-250 µg/ml. Cell viability was assessed using the MTT method. Data are presented as mean ± SD, *; P<0.05 as compared to -ve control, n=3. + ve Control; doxorubicin at 100 µM.
Fig. 2.
Effects of co-administration of E1 (50 µg/ml) and doxorubicin (0.1, 1 and 10 µM) on viability of MCF-7 cell line (5 × 10 4 cell/ml). Cell viability was assessed using the MTT method. Data are presented as mean ± SD, n=3. ■, and ▲ representing P<0.05 comparing to the negative (-ve) control, doxorubicin and E1, respectively.
The results of concurrent administration of E2 (50 µg/ml) with doxorubicin at different concentrations (0.1, 1, 10 µM) on MCF-7 cells are shown in Fig. 3 . E2 indicated synergic effect with all concentrations of doxorubicin (P<0.05). However, the mixture of E2 at 50 µg/ml and doxorubicin at1 µM was the most effective combination.
Cytotoxic effects of E1 (50-250 µg/ml) and FW (50-250 µg/ml) on HeLa cells is depicted in Fig. 4 . Significant cytotoxic effects (P<0.05) was observed when E1 concentrations were between 150-250 µg/ml.
On the other hand, FW was cytotoxic to HeLa cells at all tested concentrations (P<0.05).
The results of co-administration of E1 at 100 µg/ml with different concentration of doxorubicin (0.1, 1, 10 µM) on HeLa cell line are illustrated in Fig. 5 . The highest toxicity was observed when E1 was mixed with doxorubicin at 1 µM (P<0.05). The IC 50 values of E1, E2, E3 and FW on MCF-7 cell line were found to be close to 70, 80, 100, and 40 µg/ml, respectively. The IC 50 values for E1 and FW on HeLa cells were around 180 and 70 µg/ml, respectively. 4 cell/ml) following exposure to concentrations between 50-250 µg/ml. Cell viability was assessed using the MTT method. Data are presented as mean ± SD, *; P<0.05 as compared to negative (-ve) control, n=3. Positive (+ve) control was doxorubicin at 100 µM. Fig. 5 . Effects of co-administration of E1 (100 µg/ml) and doxorubicin (0.1, 1 and 10 µM) on viability of HeLa cell line (5 × 10 4 cell/ml). Cell viability was assessed using the MTT method. Data are presented as mean ± SD, n=3. ■, and ▲ representing P<0.05 comparing to the negative (-ve) control, doxorubicin and E1, respectively.
DISCUSSION
In this study the volatile oils of D. sophia seeds were collected and analysed by GC and GC/MS. The results indicated that 1-buten-4-isothiocyanate or 3-butenyl isothiocyanate was the major constituent of the volatile oils. The optimum autolysis time used in this study was similar to the previous reports (17) (18) (19) .
Several studies have demonstrated the effectiveness of different extractions of D. sophia seeds on cancerous cell lines. For instance, n-butanol extract has shown cytotoxicity to NCI-H460, SF268 and SGC-7901 cell lines (4), while seed ethanolic extract was cytotoxic to A549 (11), BCG-823 and MDA-MB-435 cancerous cells (12) . The antitumor and anticancer activities of the seed extract have been attributed to the presence of active ingredients such as kaempferol, quercetine, isorhamnetine, strophanthidin and artabotryside A (20) . In the present study, the cytotoxic effects of volatile oils obtained from D. Sophia seeds , after autolysis at various times, were evaluated on MCF-7 and HeLa cell lines. Volatile oils as well as FW showed significant cell toxicity on MCF7 and HeLa cell lines. However, the results indicated that HeLa cells were less susceptible to the cytotoxic effect of the volatile oils than MCF-7. This activity could be attributed, in part, to the presence of considerable amount of 1-buten-4-isothiocianate in the volatile oils. Benzyl isothiocyanates have already been reported as apoptosis inducers (21) and cytotoxic agents which may present in the dietary regimens containing Cruciferae vegetables. The IC 50 values of 5.95, 7.32 and 77.9 µM (1, 1.2 and 14.5 µg/ml) have been reported for benzyl isothiocianate , phenethylisothiocianate and naphthyl-isothiocianate on MCF-7 cell, respectively (22) . The higher IC 50 values of the volatile oils observed in the present work could be attributed to the composition of the isothiocyanates (1-buten-4-isothiocianate versus benzyl isothiocianate) and the presence of other volatile constituents like fatty acids in the volatile oils.
In the current study, the cytotoxic effects of combination of D. sophia volatile oils with doxorubicin were also investigated in order to seek any synergistic cytotoxic effects. Although doxorubicin is widely used as chemotherapeutic agent in different malignancies, multidrug resistance is one of the major concerns associated with its application. Multidrug resistance which is characterized by reduced sensitivity of the cancerous cells to a spectrum of structurally diverse chemotherapeutic agents like anthracyclines, Vinca alkaloids, epipodophyllotoxins and their semisynthetic derivatives limits the effectiveness of chemotherapy of a variety of cancers (23) . Multidrug resistance is characterized by decreased accumulation of drugs and overexpression of a highly conserved plasma membrane glycoprotein, termed Pglycoprotein (P-GP) which acts as a drug efflux pump (24) . However, several diverse derivatives like tamoxifen, verapamil and cyclosporine A, known as multidrug-reversal agents (25) , could enhance intracellular anticancer drug accumulation via impairing the P-GP function (26) . Concurrent administration of E1and E2 with doxorubicin significantly reduced the viability of MCF-7 cell line. This observation is in accordance with the Gupta and coworkers study who reported that phenethyl-isothiocyanate has potential to enhance the cytotoxic effects of doxorubicin on MCF-7 cell line (27) .
Hu and colleagues demonstrated that benzyl-and phenethyl isothiocyanates are not P-glycoprotein substrates, as their IC 50 values were almost similar in MCF-7/ADR and wild type MCF-7 (28). It is also reported that butyl-, phenethyl-and naphthyl isothiocyanates inhibit the P-GP-mediated efflux of daunomycin, an antracycline anticancer agent (28, 29) .
As described earlier, E1 and E2 exerted synergistic cytotoxic effect on MCF-7 cells, when co-administered with doxorubicin, a drug which is a P-GP substrate. This additional cytotoxicity of doxorubicin could, in part, be attributed to the impairment of the P-GP function caused by 3-butenyl isothiocyanate, found as the major isothiocyanate of D. sophia.
Inhibition of P-GP by isothiocyanates and not being P-GP substrate at the same time makes them potential multi drug resistance (MDR) reversing and cytotoxic agent. When isothiocyanates co-administered with a P-GP substrate like doxorubicin, they could stay inside the cells longer and inhibit the efflux pump to enhance intracellular accumulation of doxorubicin.
Consequently, doxorubicin dosage could be adjusted and its severe cardiotoxic side effects will be reduced.
Hermawan and coworkers reported that ethanolic extract of Moringa oleifera, a plant from Cruciferae family, consisting phenethylisothiocyanate and benzyl-isothiocyanate was able to increase cytotoxic effect of doxorubicin on HeLa cells (29) . Our results also indicated the synergic effects of the volatile oils (50 µg/ml) with doxorubicin (1 µM) on HeLa cell line.
Papi and colleagues demonstrated that 4-methylthio-3-butenyl isothiocyanate has selective cytotoxic/apoptotic activity toward three human colon carcinoma cell lines, and very limited toxicity on normal human Tlymphocytes (30) .
The results of another study conducted by Milczarek and coworkers (31) on combination treatment of sulforaphan derivatives with 5-fluorouracil revealed the antagonistic effect of isothiocyanates and 5-fluorouracil on normal cell line while other publications had proven the synergic effect of sulforaphane and doxorubicin (32) or sulporaphane and 5-fluorouracil (33) on cancer cell lines. In case of normal cells, antagonism is a beneficial interaction and considered to be even protective for the normal cells.
At last, cytotoxic activity of isothiociantes on cancerous cell lines with no cytotoxic effects on normal cells as well as their P-GP inhibitory activity and not being the P-GP substrate make them potential target to encourage new researches for cancer chemotherapy.
CONCLUSION
Cytotoxic evaluation of D. sophia volatile oils with various degrees of autolysis showed great cell toxicity on MCF-7 and HeLa cell lines. MCF-7 cells, however, were more susceptible than HeLa cell line. Cocurrent use of E1 and E2 with doxorubicin more significantly reduced the viability of MCF-7 and HeLa cells compared to each individual compound.
